Serif Biomedicines Presents Data at ASGCT 2026 Demonstrating the Potential of Modified DNA as a New Class of Genetic Medicines May 12 '26
‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class Apr 28 '26 Genetic & Engineering News ↗︎
Scaling Bio 008: Serif Biomedicines’ Jake Rubens on Turning Modified DNA into a New Class of Medicine Apr 21 '26 Decoding Bio ↗︎
Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology Apr 21 '26
Flagship Pioneering launches Cambridge biotech to develop modified DNA as new drug class Apr 21 '26 Boston Business Journal ↗︎
With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines Apr 21 '26 Fierce Biotech ↗︎
Flagship’s Latest Startup Aims to Solve Gene Therapy’s Thorniest Technical Challenge Apr 21 '26 Endpoints News ↗︎